Please assess the completion status of the following clinical trial:

Trial Title: Neocartilage Implant to Treat Cartilage Lesions of the Knee

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Generally, the following inclusion criteria must be met, however, this is not a complete list.~* Male or Female between the ages of 18 and 60~* (1) or (2) articular cartilage lesions of the distal femur ranging in no more than 5 cm2 each~* Ipsilateral knee compartment has intact menisci (or meniscectomized remnant with \> 5mm wide rim) and stable ligaments in the affected knee~* 3 months out from initiation of conservative non-surgical management (e.g.hyaluronic acid injection, activity modification) or previous minimal surgical intervention (e.g., arthroscopic lavage, debridement) or 12 months out from marrow stimulation for this condition~Exclusion Criteria:~Generally, if a potential participant meets any of the following criterions, they will not be eligible for this study. Additionally, more criteria will be evaluated to confirm eligibility as this list is not a complete list of criteria.~* Osteoarthritis~* Rheumatoid arthritis~* History of septic or reactive arthritis~* Gout or a history of gout or pseudo-gout in the affected knee~* Osteochondritis dissecans or osteochondral lesions of the knee with bone loss \> 6mm deep~* Bipolar articular cartilage involvement (or kissing lesions) of the ipsilateral compartment (i.e., \> than ICRS Grade 2 on the opposing articular surface)~* Associated damage to the underlying subchondral bone requiring an osteochondral graft~* Is pregnant or breast-feeding~* Has a BMI \> 35 (kg/m2)~* Has prior total meniscectomy of either knee~* Has received, within the past three months, intra-articular hyaluronic acid therapy, or steroid therapy~* Has more than two clinically relevant chondral lesion(s) on the index knee

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Neocartilage Implant (Type: ACTIVE_COMPARATOR): Neocartilage Implant surgically implanted and affixed to subchondral bone using commercial fibrin during mini-open knee arthrotomy.
- Microfracture (Type: OTHER): Standard of care cartilage repair technique.

Based on this trial design, predict the completion outcome and termination type (if applicable).